Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price objective reduced by stock analysts at HC Wainwright from $28.00 to $25.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside […]
Ribbon Communications (NASDAQ:RBBN – Free Report) had its target price lifted by B. Riley from $6.00 to $6.50 in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the communications equipment provider’s stock. Separately, StockNews.com upgraded shares of Ribbon Communications from a hold rating to a buy rating […]
Cutter & CO Brokerage Inc. reduced its holdings in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 4.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 19,234 shares of the company’s stock after selling 875 shares during the period. PepsiCo makes up 0.9% of Cutter & CO Brokerage Inc.’s investment portfolio, […]
CNBC Pro screened for global stocks that have had their upside potential
Alphabet (NASDAQ:GOOGL – Get Free Report) had its target price upped by TD Cowen from $170.00 to $200.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the information services provider’s stock. TD Cowen’s target price indicates a potential upside of 16.73% from the company’s current price. […]
KeyCorp dropped their price objective on Meta Platforms from $575.00 to $555.00 and set an "overweight" rating on the stock in a report on Monday.
Crypto analyst Javon Marks has laid out an ultra-bullish narrative for the XRP price, predicting that the crypto token’s price could increase exponentially to triple figures. The analyst also alluded to XRP’s historical price pattern to show that this price move was possible. XRP Price Could Rise Above $200 Javon Marks mentioned in an X […]
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) rose 2.8% during mid-day trading on Thursday after Citigroup raised their price target on the stock from $88.00 to $89.00. Citigroup currently has a buy rating on the stock. CRISPR Therapeutics traded as high as $57.19 and last traded at $57.11. Approximately 273,490 shares changed […]
CSX (NASDAQ:CSX – Free Report) had its price objective boosted by Stifel Nicolaus from $37.00 to $39.00 in a report issued on Friday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the transportation company’s stock. CSX has been the subject of a number of other research reports. Jefferies Financial Group began coverage on […]
Hub Group (NASDAQ:HUBG – Get Free Report) had its target price decreased by research analysts at Evercore ISI from $46.00 to $44.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the transportation company’s stock. Evercore ISI’s price target indicates a potential upside of 9.29% from the […]
Strategic Education (NASDAQ:STRA – Free Report) had its price objective increased by Barrington Research from $125.00 to $135.00 in a research report released on Thursday morning, Benzinga reports. They currently have an outperform rating on the health services provider’s stock. A number of other analysts have also recently issued reports on STRA. TheStreet raised Strategic […]
Meta Platforms (NASDAQ:META – Get Free Report) had its target price reduced by Raymond James from $550.00 to $525.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “strong-buy” rating on the social networking company’s stock. Raymond James’ price target would suggest a potential upside of 20.49% from the company’s […]